Market by Type (Expanded Polytetrafluoroethylene (ePTFE), Polyurethane, Polyethylene Terephthalate (PET), Other Types) Blood Vessel Diameter (Large , Medium, Small) Patient Demographic (Adult, Pediatric) Application (Aortic Disease, Peripheral Artery, Hemodialysis) End-User (Hospital, Specialty Clinics, Ambulatory Surgical Center, Other End-User) and Country Outlook | Forecast 2024-2032
Triton Market Research’s report estimates that the Middle East and Africa artificial blood vessels market is set to advance in terms of revenue at a CAGR of 6.48% during the forecast period 2024-2032.
​​Report scope can be customized per your requirements - Request Free Sample Report
The artificial blood vessels market in the Middle East and Africa is experiencing growth driven by advancements in healthcare infrastructure and government initiatives aimed at improving medical care. Several governments are investing in the development of healthcare systems to address the increasing incidence of cardiovascular diseases, which demand advanced vascular grafts and artificial blood vessels. The UAE, for instance, has been at the forefront of healthcare innovation, supporting initiatives through partnerships between public and private sectors to improve medical technologies and patient care.Â
The countries mentioned in this region include:Â
Saudi Arabia leads the regional market, reporting around $51.48 million in 2023
Saudi Arabia is strengthening its healthcare capabilities, especially in the production of plasma-derived medicines, which are often crucial in surgeries that involve artificial blood vessels.
The involvement of the Public Investment Fund (PIF) in such collaborations reflects a government-backed strategy to expand and enhance medical technologies, facilitating growth in markets such as artificial blood vessels​.
The rise in cardiovascular diseases has led to increased adoption of artificial grafts and innovations in minimally invasive vascular surgeries. The growing network of hospitals and blood banks further supports the surgical infrastructure necessary for these advanced treatments.
Market Forecast for the United Arab Emirates
The artificial blood vessels market in the United Arab Emirates (UAE) is closely linked to the country’s broader commitment to advancing healthcare via innovative technologies. The nation has implemented several initiatives aimed at fostering the growth of medical technologies, including artificial blood vessels. One of the most significant efforts is the Dubai 3D Printing Strategy, which targets the healthcare sector as a key focus. This initiative aims to position Dubai as a global leader in 3D printing by 2030, emphasizing the development of medical products such as artificial organs, bones, and surgical devices. By 2025, the Dubai Health Authority plans to produce 3D-printed artificial limbs at an affordable cost, showcasing the government’s proactive stance in promoting advanced medical solutions​.
The market is segmented into type, blood vessel diameter, patient demographic, application, and end-user. The application segment includes hemodialysis, aortic disease, and peripheral artery.Â
Peripheral artery applications involve using grafts to treat conditions affecting the arteries that supply blood to the legs, arms, and other peripheral areas of the body. The main condition requiring these grafts is peripheral artery disease (PAD), where arteries become narrowed or blocked by plaque buildup (atherosclerosis). In severe cases of PAD, artificial grafts are used in bypass surgeries to redirect blood flow around the blocked artery, restoring circulation to the affected limb.
Contender Analysis in the Artificial Blood Vessels Market:
MedicalExpo is an online platform designed for healthcare professionals and industry stakeholders. It features a comprehensive directory of medical equipment, products, and services from a wide range of manufacturers and suppliers. Offering detailed product descriptions and technical specifications, the platform connects buyers with sellers, simplifying the procurement process and supporting the search for medical solutions.
Other major firms in the market comprise Medtronic Plc, WL Gore and Associates Inc, Getinge AB, and Roumai Medical.
KEY DELIVERABLES OF THE REPORT:
Market CAGR during the forecasting years 2024-2032
Detailed data highlighting key insights, industry components, and market strategies
Comprehensive information and estimation of the artificial blood vessels market revenue growth in the Middle East and Africa and its influence on the parent market
In-depth study of forthcoming trends in consumer behavioral patterns
A meticulous analysis of the competitive landscape and Porter’s Five Forces
A wide-ranging study of factors that will challenge the Middle East and Africa artificial blood vessels market’s growth during the upcoming years
Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS
MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. PORTER’S FIVE FORCES ANALYSIS
2.1.1. THREAT OF NEW ENTRANTS
2.1.2. THREAT OF SUBSTITUTES
2.1.3. BARGAINING POWER OF BUYERS
2.1.4. BARGAINING POWER OF SUPPLIERS
2.1.5. THREAT OF COMPETITIVE RIVALRY
2.2. MARKET MATURITY ANALYSIS
2.3. SUPPLY CHAIN ANALYSIS
2.3.1. RAW MATERIALS
2.3.2. MANUFACTURERS
2.3.3. DISTRIBUTORS
2.3.4. END-USER
2.4. REGULATORY FRAMEWORK
2.5. KEY BUYING IMPACT ANALYSIS
2.5.1. BIOCOMPATIBILITY
2.5.2. DURABILITY AND LONGEVITY
2.5.3. CUSTOMIZATION AND VERSATILITY
2.5.4. REGULATORY COMPLIANCE AND QUALITY ASSURANCE
2.6. KEY MARKET STRATEGIES
2.6.1. COLLABORATIONS
2.6.2. PRODUCT LAUNCHES
2.6.3. ACQUISITIONS
2.6.4. BUSINESS DIVESTITURES & EXPANSIONS
2.7. MARKET DRIVERS
2.7.1. RISING RATES OF CARDIOVASCULAR DISEASES AND
VASCULAR DISORDERS
2.7.2. DEVELOPMENTS IN TISSUE ENGINEERING AND
REGENERATIVE MEDICINE
2.7.3. AGING POPULATION AND SHIFTING LIFESTYLES
2.8. MARKET CHALLENGES
2.8.1. EXPENSES IN THE DEVELOPMENT AND
COMMERCIALIZATION OF ARTIFICIAL BLOOD VESSELS
2.8.2. STRICT REGULATORY APPROVALS AND CLINICAL
TRIAL REQUIREMENTS
2.8.3. CHALLENGES RELATED TO BIOCOMPATIBILITY AND
LONG-TERM DURABILITY
2.9. MARKET OPPORTUNITIES
2.9.1. ADVANCEMENTS IN 3D BIOPRINTING FOR TAILORED
VASCULAR GRAFTS
2.9.2. USE OF NANOTECHNOLOGY AND BIOMIMETIC
MATERIALS TO ENHANCE FUNCTIONALITY
2.10. ANALYST PERSPECTIVE
3. MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD
VESSELS MARKET – BY TYPE
3.1. EXPANDED POLYTETRAFLUOROETHYLENE (EPTFE)
3.2. POLYETHYLENE TEREPHTHALATE (PET)
3.3. POLYURETHANE
3.4. OTHER TYPES
4. MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD
VESSELS MARKET – BY BLOOD VESSEL DIAMETER
4.1. LARGE
4.2. MEDIUM
4.3. SMALL
5. MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD
VESSELS MARKET – BY PATIENT DEMOGRAPHIC
5.1. PEDIATRIC
5.2. ADULT
6. MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD
VESSELS MARKET – BY APPLICATION
6.1. PERIPHERAL ARTERY
6.2. HEMODIALYSIS
6.3. AORTIC DISEASE
7. MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD
VESSELS MARKET – BY END-USER
7.1. HOSPITAL
7.2. SPECIALTY CLINIC
7.3. AMBULATORY SURGICAL CENTER
7.4. OTHER END-USERS
8. MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD
VESSELS MARKET – BY COUNTRY OUTLOOK
8.1. MIDDLE EAST AND AFRICA
8.1.1. UNITED ARAB EMIRATES
8.1.1.1. UNITED ARAB EMIRATES ARTIFICIAL
BLOOD VESSELS MARKET FORECAST & PROSPECTS
8.1.2. SAUDI ARABIA
8.1.2.1. SAUDI ARABIA ARTIFICIAL
BLOOD VESSELS MARKET FORECAST & PROSPECTS
8.1.3. ISRAEL
8.1.3.1. ISRAEL ARTIFICIAL BLOOD
VESSELS MARKET FORECAST & PROSPECTS
8.1.4. SOUTH AFRICA
8.1.4.1. SOUTH AFRICA ARTIFICIAL
BLOOD VESSELS MARKET FORECAST & PROSPECTS
8.1.5. REST OF MIDDLE EAST & AFRICA
8.1.5.1. REST OF MIDDLE EAST &
AFRICA ARTIFICIAL BLOOD VESSELS MARKET FORECAST & PROSPECTS
9. COMPETITIVE LANDSCAPE
9.1. BECTON, DICKINSON AND COMPANY
9.1.1. OVERVIEW
9.1.2. PORTFOLIO
9.1.3. KEY STRENGTHS
9.1.4. KEY CHALLENGE
9.2. LEMAITRE VASCULAR INC
9.2.1. OVERVIEW
9.2.2. PORTFOLIO
9.2.3. KEY STRENGTHS
9.2.4. KEY CHALLENGE
9.3. MEDTRONIC PLC
9.3.1. OVERVIEW
9.3.2. PORTFOLIO
9.3.3. KEY STRENGTH
9.3.4. KEY CHALLENGE
9.4. TERUMO MEDICAL CORPORATION
9.4.1. OVERVIEW
9.4.2. PORTFOLIO
9.4.3. KEY STRENGTHS
9.4.4. KEY CHALLENGE
9.5. W. L. GORE AND ASSOCIATES INC
9.5.1. OVERVIEW
9.5.2. PORTFOLIO
9.5.3. KEY STRENGTHS
9.5.4. KEY CHALLENGES
9.6. GETINGE AB
9.6.1. OVERVIEW
9.6.2. PORTFOLIO
9.6.3. KEY STRENGTHS
9.6.4. KEY CHALLENGE
9.7. ROUMAI MEDICAL
9.7.1. OVERVIEW
9.7.2. PORTFOLIO
9.7.3. KEY STRENGTHS
9.7.4. KEY CHALLENGES
9.8. MEDICALEXPO
9.8.1. OVERVIEW
9.8.2. PORTFOLIO
9.8.3. KEY STRENGTHS
9.8.4. KEY CHALLENGES
9.9. VASCULAR GRAFT SOLUTIONS
9.9.1. OVERVIEW
9.9.2. PORTFOLIO
9.9.3. KEY STRENGTHS
9.9.4. KEY CHALLENGES
9.10. JIANGSU BIODA LIFE SCIENCE CO LTD
9.10.1. OVERVIEW
9.10.2. PORTFOLIO
9.10.3. KEY STRENGTHS
9.10.4. KEY CHALLENGE
10. RESEARCH METHODOLOGY & SCOPE
10.1. RESEARCH SCOPE & DELIVERABLES
10.2. SOURCES OF DATA
10.3. RESEARCH METHODOLOGY
TABLE 1: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
TYPE, 2024-2032 (IN $ MILLION)
TABLE 8: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
BLOOD VESSEL DIAMETER, 2024-2032 (IN $ MILLION)
TABLE 9: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
PATIENT DEMOGRAPHIC, 2024-2032 (IN $ MILLION)
TABLE 10: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
APPLICATION, 2024-2032 (IN $ MILLION)
TABLE 11: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
END-USER, 2024-2032 (IN $ MILLION)
TABLE 12: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
FIGURE 1: MARKET MATURITY ANALYSIS
FIGURE 2: SUPPLY CHAIN ANALYSIS
FIGURE 3: KEY BUYING IMPACT ANALYSIS
FIGURE 4: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
TYPE, 2023 & 2032 (IN %)
FIGURE 5: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
EXPANDED POLYTETRAFLUOROETHYLENE (EPTFE), 2024-2032 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY POLYETHYLENE
TEREPHTHALATE (PET), 2024-2032 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
POLYURETHANE, 2024-2032 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
OTHER TYPES, 2024-2032 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
BLOOD VESSEL DIAMETER, 2023 & 2032 (IN %)
FIGURE 10: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
LARGE, 2024-2032 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
MEDIUM, 2024-2032 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
SMALL, 2024-2032 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
PATIENT DEMOGRAPHICS, 2023 & 2032 (IN %)
FIGURE 14: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
PEDIATRIC, 2024-2032 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
ADULT, 2024-2032 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
APPLICATION, 2023 & 2032 (IN %)
FIGURE 17: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
PERIPHERAL ARTERY, 2024-2032 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
HEMODIALYSIS, 2024-2032 (IN $ MILLION)
FIGURE 19: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
AORTIC DISEASE, 2024-2032 (IN $ MILLION)
FIGURE 20: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
END-USER, 2023 & 2032 (IN %)
FIGURE 21: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
HOSPITAL, 2024-2032 (IN $ MILLION)
FIGURE 22: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
SPECIALTY CLINIC, 2024-2032 (IN $ MILLION)
FIGURE 23: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
ONLINE PHARMACY, 2024-2032 (IN $ MILLION)
FIGURE 24: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
OTHER END-USERS, 2024-2032 (IN $ MILLION)
FIGURE 25: MIDDLE EAST AND AFRICA ARTIFICIAL BLOOD VESSELS MARKET, BY
COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 26: UNITED ARAB EMIRATES ARTIFICIAL BLOOD VESSELS MARKET 2024-2032
(IN $ MILLION)
FIGURE 27: SAUDI ARABIA ARTIFICIAL BLOOD VESSELS MARKET 2024-2032 (IN $
MILLION)
FIGURE 28: ISRAEL ARTIFICIAL BLOOD VESSELS MARKET 2024-2032 (IN $
MILLION)
FIGURE 29: SOUTH AFRICA ARTIFICIAL BLOOD VESSELS MARKET 2024-2032 (IN $
MILLION)
FIGURE 30: REST OF MIDDLE EAST & AFRICA ARTIFICIAL BLOOD VESSELS
MARKET 2024-2032 (IN $ MILLION)